Skip to Main content Skip to Navigation


...
inserm-01636873v1  Journal articles
Clément BaillyPierre-François CléryAlain Faivre-ChauvetMickael BourgeoisFrançois Guérard et al.  Immuno-PET for Clinical Theranostic Approaches
International Journal of Molecular Sciences, MDPI, 2016, 18 (1), Epub ahead of print. ⟨10.3390/ijms18010057⟩
hal-02415080v1  Journal articles
François GuérardJacques BarbetFerid HaddadMichel CherelFrancoise Kraeber-Bodere et al.  Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutic, 2015
in2p3-00289288v1  Journal articles
Ferid HaddadL. FerrerArnaud GuertinT. CarlierNathalie Michel et al.  ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2008, 35, pp.1377-1387. ⟨10.1007/s00259-008-0802-5⟩
...
hal-01082286v1  Directions of work or proceedings
Charbel KoumeirM. CherelArnaud GuertinFerid HaddadVincent Métivier et al.  Beam monitoring and dosimetry tools for radiobiology experiments at the cyclotron ARRONAX
International Conference on Translational research in Radiation Oncology / Physics for Health in Europe 2014, Genève, Switzerland. 110 (Supplement 1), pp.S53-S54, 2014, Radiotherapy & Oncology
hal-01082416v1  Directions of work or proceedings
Ferid HaddadL. FerrerArnaud GuertinNathalie MichelT. Carlier et al.  Evaluation of potential innovative positron-emitting radionuclides for PET applications
Annual Congress of the EANM, Oct 2006, Athens, Greece. 33 (Issue 2 Supplement), pp.228, 2006, ⟨10.1007/s00259-006-0216-1⟩